This study elucidates a novel pathological mechanism of pulmonary vascular injury during si-ALI and highlights the potential of targeting GBP2 as a promising therapeutic approach to mitigate si-ALI. The gene discussed is GBP2; the disease is acute respiratory distress syndrome.